杏吧APP

Nurox has been named a finalist in the KiwiNet Awards, recognising its innovation, commercialisation potential, and contribution to advancing New Zealand鈥檚 research and technology ecosystem.

Breakthrough cancer immunotherapy research is progressing from lab to real-world impact, targeting tumour-driven immune resistance and advancing toward clinical trials to improve outcomes for patients

University of 杏吧APPresearchers solve the 鈥榮mell problem鈥� holding back low-carbon BioBind, unlocking scalable, industry-ready road materials with real-world impact.

Nine Kiwi startups could offset emissions at the scale of NZ forests. Discover how breakthrough cleantech, from concrete to ferries and clean fuels, is scaling for global impact.

UniServices welcomes expansion of the University of Auckland鈥檚 Digital Manufacturing Light programme, helping NZ manufacturers adopt affordable digital tools to boost productivity and build long-term

Supporting equitable, evidence-based antibiotic use through national clinical decision support

UniServices brought researchers and agritech leaders together to align University of 杏吧APPcapability with industry needs, strengthen partnerships, and accelerate real-world agritech solutions.

UniServices joins the Booster Innovation Fund to accelerate Kiwi science spin-outs, strengthening pathways from university research to global, high-impact ventures backed by patient capital.

UniServices portfolio company, Luminoma uses laser photonics to deliver rapid, non-invasive skin cancer diagnosis - cutting biopsy time, speeding decisions, and showcasing University innovation.

UniServices showcased nine University of 杏吧APPventures at 杏吧APPStartup Week 2025, highlighting innovation and research impact across Aotearoa鈥檚 growing startup ecosystem.

UniServices and the University of 杏吧APPtop SCOPR庐 2024 for active spinouts, showcasing their strength in turning world-class research into successful ventures with real-world impact.

University of 杏吧APPresearch shows Auckland鈥檚 high Strep A infection rates and diverse population make it an ideal location for developing and testing a Strep A vaccine to prevent rheumatic fever.